Search

everythinglearnresearchcommunity

for

Search:↓

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Blood pressure that doesn't drop at night is linked to worse blood vessel function in people with high blood pressure.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Using high doses and multiple drugs with steroids is risky and should be prevented.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

ADAM17 could be a potential target for treating PCOS.

Hair loss linked to higher heart disease risk in both men and women.